Lilly's weight loss drug Zepbound prevents diabetes as well as helping people lose weight, company claims Hotspots ranked Start the day smarter ☀️ Funniest cap messages Get the USA TODAY app ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while ...

A five-year trial of the weight loss drug tirzepatide in Greater Manchester was announced last October ...

Novo Nordisk A/S and Eli Lilly & Co, the pharmaceutical giants dominating the global obesity drug market, now face their ...

Eli Lilly said it has started selling single-dose vials of its uber-popular weight loss drug Zepbound as demand soars – and the smaller doses cost 50% less than all other obesity medicines.

Drug manufacturer Eli Lilly announced Tuesday that its flagship weight loss medication, Zepbound, is now available for patient use.. Tirzepatide, its active ingredient, had been approved by the US ...

On Wednesday, Lilly undercut that price with its newly approved weight-loss drug Zepbound. The drugmaker said it plans to charge more than 21% less — or about $1,060 a month — for its shot ...

What other weight loss drugs is Lilly developing? Retatrutide is not Lilly’s only weight loss drug. Tirzepatide has already received FDA approval under the brand name Mounjaro to improve glucose ...

Retatrutide is not Lilly’s only weight loss drug. Tirzepatide has already received FDA approval under the brand name Mounjaro to improve glucose control in those with type 2 diabetes, ...

Eli Lilly (LLY.N), opens new tab said on Wednesday its weight-loss drug helped reduce episodes of irregular breathing associated with a common sleep-related disorder in two late-stage trials ...

Eli Lilly will ship the two highest doses of its popular weight-loss drug Zepbound to cash-paying customers on its website starting early August, the U.S. drugmaker said on Monday.